|
|||||
|
|
| 圣和散联合介入治疗消化道肿瘤肝转移临床研究 | |
| 引用本文： | 夏跃胜,王建华,宋兴荣,刘星. 圣和散联合介入治疗消化道肿瘤肝转移临床研究[J]. 时珍国医国药, 2001, 12(8): F003-F003,F004 |
| 作者姓名： | 夏跃胜 王建华 宋兴荣 刘星 |
| 作者单位： | 1. 中国人民解放军总后勤部第五职工医院, 2. 山西中医学院, |
| 基金项目： | 山西省科委科技攻关项目(No.002059) |
| 摘 要： | 目的观察中药圣和散联合肝动脉介入对消化道肿瘤肝转移的疗效.方法54例消化道肿瘤肝转移患者随机分成两组,治疗组28例采用圣和散联合介入化疗,对照组26例采用单纯介入化疗.结果近期有效率治疗组为46.43%,对照组为30.77%,两组比较有显著性差异(P＜0.05).治疗组0.5,1,2,3年生存率分别为92.86%,71.43%,46.43%和28.57%,明显优于对照组的84.62%,61.54%,26.92%和11.54%(P＜0.05).治疗组平均生存期23.4个月,优于对照组的16.4个月(P＜0.05).同时发现治疗组能明显改善临床症状,调节细胞免疫功能和降低AFP,无明显毒副作用.结论圣和散联合介入治疗能明显提高消化道肿瘤肝转移患者生活质量,延长生存期. |
| 关 键 词： | 转移性 化学栓塞 治疗 圣和散 消化道肿瘤 |
| 文章编号： | 1008-0805(2001)08-3-02 |
Clinical Study on Treating Liver Metastases from Digestive Tract Cancer with Shenghe Powder Combined with Interventional Therapy |
|
| XIA Yue-sheng ,WANG Jian-hua ,SONG Xing-rong ,LIU Xing. Clinical Study on Treating Liver Metastases from Digestive Tract Cancer with Shenghe Powder Combined with Interventional Therapy[J]. Lishizhen Medicine and Materia Medica Research, 2001, 12(8): F003-F003,F004 | |
| Authors: | XIA Yue-sheng WANG Jian-hua SONG Xing-rong LIU Xing |
| Affiliation: | XIA Yue-sheng 1,WANG Jian-hua 1,SONG Xing-rong 1,LIU Xing 2 |
| Abstract: | |
| Keywords: | Liver cancer Secondary/therapy Chemoe mbolization Shenghe powder |
| 本文献已被 CNKI 万方数据 等数据库收录！ | |